Heart failure (HF) demonstrates an epidemic-shaped growth worldwide and continues to be
a staggering health problem regardless of unprecedented efforts in diagnosis and treatment …

Introduction Fetuin‐A has been described to correlate inversely with vascular calcification
both in animal models but also in patients with heart and renal disease. In this current study …

Objective Inflammation and dystrophic calcification have been associated with
cardiovascular disease (CVD) and chronic heart failure (CHF). The aim of the present study …

Fetuin was first isolated from bovine serum in 1944. It is now most commonly known as
either fetuin-A or alpha-2-HS-glycoprotein (AHSG), the protein product of Ahsg gene. A …

Background. Fetuin-A, also called Alpha 2-Heremans Schmid Glycoprotein, is a
multifunctional plasma agent what has been proven in animal and human studies. It plays a …

Objectives Fetuin-A is a circulating glycoprotein, formed in the liver. It regulates bone
remodelling and calcium metabolism. Fetuin-A has adipogenic properties, so fat …

Background It has been suggested that fetuin-A may be a potential biomarker of
cardiometabolic disease. However, few studies have investigated preanalytical factors that …

Background Fetuin-B, a cytokine that regulates lipid metabolism, has recently been linked to
cardiovascular diseases such as coronary heart disease. In this study, we discussed the …

Fetuin-A, also termed alpha2-Heremans-Schmid glycoprotein, is a 46 kDa hepatocyte
derived protein (hepatokine) and serves multifaceted functions.(i) It acts as systemic inhibitor …

Previous studies on serum fetuin‐B (fetuin‐like protein IRL685) have investigated its
association with T2DM; however, the reason for the variation in serum fetuin‐B and its …